Immune correlates of clinical benefit in a phase I study of hyperthermia with adoptive T cell immunotherapy in patients with solid tumors

References

• Ren J, Gwin WR, Zhou X, et al. Adaptive T cell responses induced by oncolytic Herpes Simplex Virus-granulocyte macrophage-colony-stimulating factor therapy expanded by dendritic cell and cytokine-induced killer cell adoptive therapy. Oncoimmunology. 2017;6:e1264563.
   PubMed Web of Science ®Google Scholar
• Qiao G, Wang X, Zhou L, et al. Autologous dendritic cell-cytokine induced killer cell immunotherapy combined with S-1 plus cisplatin in patients with advanced gastric cancer: a prospective study. Clin Cancer Res. 2019;25:1494–1504.
   PubMed Web of Science ®Google Scholar
• Jiang N, Qiao G, Wang X, et al. Dendritic cell/cytokine-induced killer cell immunotherapy combined with S-1 in patients with advanced pancreatic cancer: a prospective study. Clin Cancer Res. 2017;23:5066–5073.
   PubMed Web of Science ®Google Scholar
• Roti Roti JL. Cellular responses to hyperthermia (40-46 degrees C): cell killing and molecular events. Int J Hypertherm. 2008;24:3–15.
   PubMed Web of Science ®Google Scholar
• Crezee J, van Leeuwen CM, Oei AL, et al. Biological modelling of the radiation dose escalation effect of regional hyperthermia in cervical cancer. Radiat Oncol. 2016;11:14.
   PubMed Web of Science ®Google Scholar
• Abe M, Hiraoka M, Takahashi M, et al. Multi-institutional studies on hyperthermia using an 8-MHz radiofrequency capacitive heating device (Thermotron RF-8) in combination with radiation for cancer therapy. Cancer. 1986;58:1589–1595.
   PubMed Web of Science ®Google Scholar
• Ohguri T, Imada H, Yahara K, et al. Radiotherapy with 8-MHz radiofrequency-capacitive regional hyperthermia for stage III non-small-cell lung cancer: the radiofrequency-output power correlates with the intraesophageal temperature and clinical outcomes. Int J Radiat Oncol Biol Phys. 2009;73:128–135.
   PubMed Web of Science ®Google Scholar
• Harima Y, Nagata K, Harima K, et al. A randomized clinical trial of radiation therapy versus thermoradiotherapy in stage IIIB cervical carcinoma. 2001. Int J Hypertherm. 2009;25:338–343.
   PubMed Web of Science ®Google Scholar
• Harima Y, Ohguri T, Imada H, et al. A multicentre randomised clinical trial of chemoradiotherapy plus hyperthermia versus chemoradiotherapy alone in patients with locally advanced cervical cancer. Int J Hypertherm. 2016;32:801–808.
   PubMed Web of Science ®Google Scholar
• Huilgol NG, Gupta S, Sridhar CR. Hyperthermia with radiation in the treatment of locally advanced head and neck cancer: a report of randomized trial. J Can Res Ther. 2010;6:492–496.
   PubMed Web of Science ®Google Scholar
• Mitsumori M, Zeng ZF, Oliynychenko P, et al. Regional hyperthermia combined with radiotherapy for locally advanced non-small cell lung cancers: a multi-institutional prospective randomized trial of the International Atomic Energy Agency. Int J Clin Oncol. 2007;12:192–198.
   PubMed Web of Science ®Google Scholar
• Court KA, Hatakeyama H, Wu SY, et al. HSP70 inhibition synergistically enhances the effects of magnetic fluid hyperthermia in ovarian cancer. Mol Cancer Ther. 2017;16:966–976.
   PubMed Web of Science ®Google Scholar
• Chen T, Guo J, Han C, et al. Heat shock protein 70, released from heat-stressed tumor cells, initiates antitumor immunity by inducing tumor cell chemokine production and activating dendritic cells via TLR4 pathway. J Immunol. 2009;182:1449–1459.
   PubMed Web of Science ®Google Scholar
• Joshi N, Duhan V, Lingwal N, et al. Adjuvant properties of thermal component of hyperthermia enhanced transdermal immunization: effect on dendritic cells. PloS One. 2012;7:e32067.
   PubMed Web of Science ®Google Scholar
• Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14:199–208.
   PubMed Web of Science ®Google Scholar
• Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649–655.
   PubMed Web of Science ®Google Scholar
• Nishino M, Jackman DM, Hatabu H, et al. New Response Evaluation Criteria in Solid Tumors (RECIST) guidelines for advanced non-small cell lung cancer: comparison with original RECIST and impact on assessment of tumor response to targeted therapy. Am J Roentgenol. 2010;195:W221–W228.
   PubMed Web of Science ®Google Scholar
• Shoji H, Motegi M, Osawa K, et al. Output-limiting symptoms induced by radiofrequency hyperthermia. Are they predictable?. Int J Hypertherm. 2016;32:199–203.
   PubMed Web of Science ®Google Scholar
• Shoji H, Motegi M, Osawa K, et al. A novel strategy of radiofrequency hyperthermia (neothermia) in combination with preoperative chemoradiotherapy for the treatment of advanced rectal cancer: a pilot study. Cancer Med. 2015;4:834–843.
   PubMed Web of Science ®Google Scholar
• Sufficool KE, Lockwood CM, Abel HJ, et al. T-cell clonality assessment by next-generation sequencing improves detection sensitivity in mycosis fungoides. J Am Acad Dermatol. 2015;73:228–236.e2.
   PubMed Web of Science ®Google Scholar
• Huang H, Sikora MJ, Islam S, et al. Select sequencing of clonally expanded CD8(+) T cells reveals limits to clonal expansion. Proc Natl Acad Sci U S A. 2019;116:8995–9001.
   PubMed Web of Science ®Google Scholar
• Robert L, Tsoi J, Wang X, et al. CTLA4 blockade broadens the peripheral T-cell receptor repertoire. Clin Cancer Res. 2014;20:2424–2432.
   PubMed Web of Science ®Google Scholar
• Rempala GA, Seweryn M. Methods for diversity and overlap analysis in T-cell receptor populations. J Math Biol. 2013;67:1339–1368.
   PubMed Web of Science ®Google Scholar
• Qi Q, Liu Y, Cheng Y, et al. Diversity and clonal selection in the human T-cell repertoire. Proc Natl Acad Sci U S A. 2014;111:13139–13144.
   PubMed Web of Science ®Google Scholar
• Fujimoto S, Kobayashi K, Takahashi M, et al. Clinical pilot studies on pre-operative hyperthermic tumour ablation for advanced breast carcinoma using an 8 MHz radiofrequency heating device. Int J Hypertherm. 2003;19:13–22.
   PubMed Web of Science ®Google Scholar
• Mochiki E, Shioya M, Sakurai H, et al. Feasibility study of postoperative intraperitoneal hyperthermochemotherapy by radiofrequency capacitive heating system for advanced gastric cancer with peritoneal seeding. Int J Hypertherm. 2007;23:493–500.
   PubMed Web of Science ®Google Scholar
• Plan Sangnier A, Preveral S, Curcio A, Kas A, et al. Targeted thermal therapy with genetically engineered magnetite magnetosomes@RGD: Photothermia is far more efficient than magnetic hyperthermia. J Control Release. 2018;279:271–281.
   PubMed Web of Science ®Google Scholar
• Youssef I, Amin NP. Radiation therapy, hyperthermia for chest wall recurrence. Treasure Island (FL): StatPearls Publishing StatPearls Publishing LLC; 2018.
   Google Scholar
• Faghih Z, Deihimi S, Talei A, et al. Analysis of T cell receptor repertoire based on Vbeta chain in patients with breast cancer. CBM. 2018;22:733–745.
   Web of Science ®Google Scholar
• Gkazi AS, Margetts BK, Attenborough T, et al. Clinical T cell receptor repertoire deep sequencing and analysis: an application to monitor immune reconstitution following cord blood transplantation. Front Immunol. 2018;9:2547.
   PubMed Web of Science ®Google Scholar
• Wieland A, Kamphorst AO, Adsay NV, et al. T cell receptor sequencing of activated CD8 T cells in the blood identifies tumor-infiltrating clones that expand after PD-1 therapy and radiation in a melanoma patient. Cancer Immunol Immunother. 2018;67:1767–1776.
   PubMed Web of Science ®Google Scholar
• Gupta SC, Kim JH, Prasad S, et al. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev. 2010;29:405–434.
   PubMed Web of Science ®Google Scholar
• Shao YY, Lin H, Li YS, et al. High plasma interleukin-6 levels associated with poor prognosis of patients with advanced hepatocellular carcinoma. Jpn J Clin Oncol. 2017;47:949–953.
   PubMed Web of Science ®Google Scholar
• Chen Q, Fisher DT, Clancy KA, et al. Fever-range thermal stress promotes lymphocyte trafficking across high endothelial venules via an interleukin 6 trans-signaling mechanism. Nat Immunol. 2006;7:1299–1308.
   PubMed Web of Science ®Google Scholar
• Fisher DT, Chen Q, Skitzki JJ, et al. IL-6 trans-signaling licenses mouse and human tumor microvascular gateways for trafficking of cytotoxic T cells. J Clin Invest. 2011;121:3846–3859.
   PubMed Web of Science ®Google Scholar
• Evans SS, Repasky EA, Fisher DT. Fever and the thermal regulation of immunity: the immune system feels the heat. Nat Rev Immunol. 2015;15:335–349.
   PubMed Web of Science ®Google Scholar
• Kong J, Kong J, Pan B, et al. Insufficient radiofrequency ablation promotes angiogenesis of residual hepatocellular carcinoma via HIF-1alpha/VEGFA. PloS One. 2012;7:e37266.
   PubMed Web of Science ®Google Scholar
• Dong S, Kong J, Kong F, et al. Insufficient radiofrequency ablation promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells through Akt and ERK signaling pathways. J Transl Med. 2013;11:273.
   PubMed Web of Science ®Google Scholar
• Duan XH, Li H, Han XW, et al. Upregulation of IL-6 is involved in moderate hyperthermia induced proliferation and invasion of hepatocellular carcinoma cells. Eur J Pharmacol. 2018;833:230–236.
   PubMed Web of Science ®Google Scholar
• Dumitriu IE. The life (and death) of CD4+ CD28(null) T cells in inflammatory diseases. Immunology. 2015;146:185–193.
   PubMed Web of Science ®Google Scholar
• Maly K, Schirmer M. Corrigendum to “The Story of CD4 (+) CD28(-) T Cells Revisited: Solved or Still Ongoing?”. J Immunol Res. 2015;2015:251657.
   PubMed Web of Science ®Google Scholar
• Filaci G, Fenoglio D, Fravega M, et al. CD8+ CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers. J Immunol. 2007;179:4323–4334.
   PubMed Web of Science ®Google Scholar
• Casado JG, Soto R, DelaRosa O, et al. CD8 T cells expressing NK associated receptors are increased in melanoma patients and display an effector phenotype. Cancer Immunol Immunother. 2005;54:1162–1171.
   PubMed Web of Science ®Google Scholar